Lipidil (fenofibrate) is the first tablet available in Australia to slow down the progression of diabetic retinopathy.
1-3 The once-a-day tablet has been approved by the TGA, and may help people with Type 2 diabetes and existing retinopathy to avoid other invasive procedures used to treat the later stages of the disease.1-4 At the 22nd World Diabetes Congress in Melbourne last year, Professor of Clinical Ophthalmology and Eye Health at the University of Sydney, Paul Mitchell, said large international trials “have shown that Lipidil can prevent progression of diabetic retinopathy to more advanced, vision threatening stages”.1-4
Contact: Abbott Australasia: 1800 225 311
References
1. The ACCORD Study Group and ACCORD Eye Study Group. N Engl J Med 2010;363(3):233-44.
2. Lipidil Approved Product Information Oct 2013.
3. Lipidil Consumer Health Information. Prepared October 2013.
4. Coyne, The impact of diabetic retinopathy: perspectives from patient focus groups,
accessed September 2013 www.fampra.oxfordjournals.org/content/21/4/447.short
[/vc_column_text][/vc_column]
